Current Organic Synthesis
Title: Editorial [The Trifluoromethyl Group in Organic Synthesis: Recent Developments (Guest Editor: Simon E. Lopez)]
Volume: 7 Issue: 5
Author(s): Simon E. Lopez
Affiliation:
Export Options
About this article
Cite this article as:
Lopez E. Simon, Editorial [The Trifluoromethyl Group in Organic Synthesis: Recent Developments (Guest Editor: Simon E. Lopez)], Current Organic Synthesis 2010; 7 (5) . https://dx.doi.org/10.2174/157017910792246108
DOI https://dx.doi.org/10.2174/157017910792246108 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Saving the Ischemic Penumbra: Potential Role for Statins and Phosphodiesterase Inhibitors
Current Vascular Pharmacology Heat Shock Proteins: Therapeutic Drug Targets for Chronic Neurodegeneration?
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
Letters in Drug Design & Discovery Clinical Application of Tissue Doppler Imaging in Coronary Artery Diseases and Heart Failure
Recent Patents on Medical Imaging Striving for a Fuller Characterization of the Cellular Neuropathology of Depression Subtypes
Current Psychiatry Reviews Editorial (Thematic Issue: Chemistry Towards Biology: Proceedings of the Katowice Conference)
Current Protein & Peptide Science The Microbiota and Gut-Brain Axis: Contributions to the Immunopathogenesis of Schizophrenia
Current Pharmaceutical Design High Throughput Screening and Structure-Activity Relationship Study of Potential α2A-Adrenoceptor Agonists by LANCETM cAMP Assay
Combinatorial Chemistry & High Throughput Screening Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry Neural and Behavioral Responses to Systemic Immunologic Stimuli: A Consideration of Bacterial T Cell Superantigens
Current Pharmaceutical Design Imaging the Earliest Stages of Alzheimers Disease
Current Alzheimer Research Editorial (Thematic Issue: The Urgent Need to Reform the Present System of Medicines’ Regulation)
Reviews on Recent Clinical Trials GSK-3 Inhibitors: A New Class of Drugs for Alzheimer’s Disease Treatment
Current Drug Targets Neurological Disorders in Medical Use of <i>Cannabis</i>: An Update
CNS & Neurological Disorders - Drug Targets Influence of Betaine- and Choline-based Eutectic Solvents on Lipase Activity
Current Biochemical Engineering (Discontinued) Glutamatergic Animal Models of Schizophrenia
Current Pharmaceutical Design Anti-Alzheimer Therapeutic Drugs Targeting γ-Secretase
Current Topics in Medicinal Chemistry Clinical and Pathophysiological Relations Between Migraine and Mood Disorders
Current Psychiatry Reviews Chemokine Network in the Nervous System: A New Target for Pain Relief
Current Medicinal Chemistry Hybrid Therapy in the Management of Atrial Fibrillation
Current Cardiology Reviews